Avaxia Biologics Garners $3,096,371 New Financing

  • Feed Type
  • Date
    5/6/2014
  • Company Name
    Avaxia Biologics
  • Mailing Address
    128 Spring Street Lexington, MA 02421 USA
  • Company Description
    Avaxia is developing oral antibody products for diseases and disease targets that can be reached through the mouth and the gastrointestinal tract.
  • Website
    http://www.avaxiabiologics.com
  • Transaction Type
    Debt
  • Transaction Amount
    $3,096,371
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    Proceeds purposes were not disclosed. SEC regulatory filing. Contact technology company for investment details, if applicable. Not an offer or solicitation for sale of securities.
  • M&A Terms
  • Venture Investor